212 related articles for article (PubMed ID: 36482903)
21. m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer.
Sheng G; Wang T; Gao Y; Wu H; Wu J
Sci Rep; 2023 Nov; 13(1):19670. PubMed ID: 37952076
[TBL] [Abstract][Full Text] [Related]
22. M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy.
Zhao K; Wei B; Zhang Y; Shi W; Zhang G; Wang Z
Front Pharmacol; 2022; 13():1052177. PubMed ID: 36438800
[No Abstract] [Full Text] [Related]
23. Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration.
Yue Q; Zhang Y; Wang F; Cao F; Bai J; Duan X
J Immunol Res; 2022; 2022():8766735. PubMed ID: 35692505
[TBL] [Abstract][Full Text] [Related]
24. Analysis of m6A Methylation Modification Patterns and Tumor Immune Microenvironment in Breast Cancer.
Dong M; Shen W; Yang G; Yang Z; Li X
Front Cell Dev Biol; 2022; 10():785058. PubMed ID: 35178386
[TBL] [Abstract][Full Text] [Related]
25. Identification of the expression patterns and potential prognostic role of m6A-RNA methylation regulators in Wilms Tumor.
Jia C; Gao H; Ma W; Liu X; Chang M; Sun F
BMC Med Genomics; 2023 Sep; 16(1):222. PubMed ID: 37735424
[TBL] [Abstract][Full Text] [Related]
26. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.
Yang Q; Xu F; Jian A; Yu H; Ye T; Hu W
Front Cell Dev Biol; 2021; 9():803141. PubMed ID: 35198565
[No Abstract] [Full Text] [Related]
27. N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes.
Wei J; Fang DL; Zhou W; He YF
J Gastrointest Oncol; 2021 Aug; 12(4):1860-1872. PubMed ID: 34532134
[TBL] [Abstract][Full Text] [Related]
28. m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer.
Cai L; Liu T; Hua H; Jiang X; Qian L
BMC Endocr Disord; 2023 Dec; 23(1):271. PubMed ID: 38057752
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma.
Ji J; Liu S; Liang Y; Zheng G
BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073
[TBL] [Abstract][Full Text] [Related]
30. Increased m6A methylation level is associated with the progression of human abdominal aortic aneurysm.
He Y; Xing J; Wang S; Xin S; Han Y; Zhang J
Ann Transl Med; 2019 Dec; 7(24):797. PubMed ID: 32042813
[TBL] [Abstract][Full Text] [Related]
31. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in patients with intracranial aneurysms.
Maimaiti A; Turhon M; Cheng X; Su R; Kadeer K; Axier A; Ailaiti D; Aili Y; Abudusalamu R; Kuerban A; Wang Z; Aisha M
Front Neurol; 2022; 13():889141. PubMed ID: 35989938
[TBL] [Abstract][Full Text] [Related]
32. Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm.
Li S; Zhang Q; Weng L; Han Y; Li J
Front Aging Neurosci; 2022; 14():973258. PubMed ID: 36034129
[TBL] [Abstract][Full Text] [Related]
33. m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia.
Xu ZJ; Wen XM; Zhang YC; Jin Y; Ma JC; Gu Y; Chen XY; Xia PH; Qian W; Lin J; Qian J
Front Genet; 2022; 13():948079. PubMed ID: 36035161
[TBL] [Abstract][Full Text] [Related]
34. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
Huang ZD; Lin LL; Liu ZZ; Hu C; Gu HY; Wei RX
Front Immunol; 2021; 12():765723. PubMed ID: 35003079
[TBL] [Abstract][Full Text] [Related]
35. m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma.
Li J; Wang W; Zhou Y; Liu L; Zhang G; Guan K; Cui X; Liu X; Huang M; Cui G; Sun R
Front Cell Dev Biol; 2021; 9():687756. PubMed ID: 34277630
[No Abstract] [Full Text] [Related]
36. An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer.
Zhou Z; Zhang J; Xu C; Yang J; Zhang Y; Liu M; Shi X; Li X; Zhan H; Chen W; McNally LR; Fung KM; Luo W; Houchen CW; He Y; Zhang C; Li M
EBioMedicine; 2021 Mar; 65():103271. PubMed ID: 33714027
[TBL] [Abstract][Full Text] [Related]
37. m6A Regulator-mediated RNA Methylation Modulates Immune Microenvironment of Hepatitis B Virus-related Acute Liver Failure.
Li D; Liu Y; Zhou J; Chen Y; Yang C; Liu H; Li W; You J
Inflammation; 2023 Oct; 46(5):1777-1795. PubMed ID: 37256461
[TBL] [Abstract][Full Text] [Related]
38. Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia.
Han S; Qi J; Fang K; Wang H; Tang Y; Wu D; Han Y
Cancer Med; 2022 Mar; 11(5):1413-1426. PubMed ID: 35023630
[TBL] [Abstract][Full Text] [Related]
39. Correlation of m6A methylation with immune infiltrates and poor prognosis in non-small cell lung cancer via a comprehensive analysis of RNA expression profiles.
Dong B; Wu C; Li SH; Huang L; Zhang C; Wu B; Sheng Y; Liu Y; Ye G; Qi Y
Ann Transl Med; 2021 Sep; 9(18):1465. PubMed ID: 34734017
[TBL] [Abstract][Full Text] [Related]
40. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
Meijing Z; Tianhang L; Biao Y
Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
